Supriya Lifescience Limited — Others, 27-01-2025: Copy of Newspaper Publication

Supriya Lifescience Ltd. has announced a board meeting on January 24, 2025, to review the financial results for the quarter and nine months ended December 31, 2024. The total income from operations for the quarter stands at ₹94.00 crore, while net profit after tax is reported at ₹46.78 crore. With solid financial performance, the anticipated results could enhance investor sentiment, reflecting stability and growth potential. The steady earnings may provide a positive outlook for shareholders, indicating effective management strategies in a competitive market.